通过人工神经网络推进制药科学:对优化药物输送系统配方的审查
Simin Salarpour1, Soodeh Salarpour2,3,4, Mehdi Ansari Dogaheh3,4
1School of Natural Sciences, University of Tasmania, Hobart, TAS, Australia.
Current pharmaceutical design
|September 27, 2024
概括
人工神经网络 (ANN) 通过分析配方因素来优化药物输送系统 (DDS). 这种计算方法增强了DDS设计,以改善药物管理和向治疗.
科学领域:
- 制药科学 制药科学
- 计算生物学 计算生物学
- 生物技术是生物技术.
背景情况:
- 传统的药物输送方法在给药,患者遵守和副作用管理方面面临挑战.
- 药物输送系统 (DDS) 旨在克服这些局限性,旨在改善治疗结果.
- 优化DDS性能需要仔细考虑配方因素.
研究的目的:
- 审查人工神经网络 (ANN) 在制药配方的设计和优化中的应用,特别是DDS.
- 要突出ANN如何在配方变量和DDS特征之间建立关系.
- 展示ANN在开发理想DDS方面的潜力.
主要方法:
- 利用人工神经网络 (ANN),以生物神经网络为灵感的计算模型.
- 根据各种DDS类型定义ANN模型的独立和依赖参数.
- 在DDS表述中分析ANN应用的各种例子.
主要成果:
- ANN模型可以有效地预测和优化各种DDS的性能特征.
- 配方因子和DDS属性之间的关系可以使用ANN.成功建立.
- ANN促进了定制DDS的开发,提高了有效性和安全性.
结论:
- 人工神经网络为药物输送系统的合理设计和优化提供了强大的计算工具.
- ANN使药物配方能够采用数据驱动的方法,从而改善药物产品的开发.
- 在DDS设计中应用ANN有望在向治疗和患者护理方面取得进展.
相关概念视频
Drug Delivery: Overview
1.3K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.3K
Modified-Release Drug Delivery Systems: Classification
318
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
318
Modified-Release Drug Delivery Systems: Stimuli-Activated
184
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
184
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165
Oral Drug Delivery Systems: Introduction
284
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
284


